GLUE — Monte Rosa Therapeutics Inc

Ownership history in MPM BioImpact LLC  ·  1 quarter on record

This page tracks every 13F SEC filing in which MPM BioImpact LLC reported a position in Monte Rosa Therapeutics Inc (GLUE). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
2.11% (2025 Q4)
Avg. % of fund
2.11%
First filed
2025 Q4
Last filed
2025 Q4
Quarters held
1
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 INITIATED 1,173,376 — — 2.11% $18.4M $15.68
% of Fund (quarterly)    GLUE price (monthly, adj. close)

Other funds also holding GLUE

As of 2025 Q4 — sorted by position size

Versant Venture Management, LLC 3Y 7Y 45.49% NEA Management Company, LLC 3Y 7Y 6.15% Aisling Capital Management LP 3Y 7Y 4.82% TCG Crossover Management, LLC 3Y 2.4% SILVERARC CAPITAL MANAGEMENT, LLC 3Y 2.24% BVF INC/IL 3Y 7Y 2.02% SUVRETTA CAPITAL MANAGEMENT, LLC 3Y 7Y 1.08% Rangeley Capital, LLC 0.88% Parkwood LLC 3Y 7Y 0.86% BRAIDWELL LP 3Y 0.48%
← Back to MPM BioImpact LLC Holdings